The relationship between uncertainty tolerance and oncologists’ perceptions of large-panel genomic tumor testing

Authors

Eric Anderson, Maine Medical Center
Alexandra Hinton, Maine Medical Center
Christine Lary
Kimberly Murray, Maine Medical Center
Leo Waterson, Maine Medical Center
Paul Han, Maine Medical CenterFollow
Maine Cancer Genomics Initiative

Document Type

Poster

Publication Date

5-1-2019

Institution/Department

Maine Medical Center Research Institute, Center for Outcomes Research and Evaluation

MeSH Headings

Oncology, Genomics

Abstract

Introduction:

Large-panel genomic tumor testing (GTT) is a new technology that promises to make cancer treatment more precise, but that currently poses many uncertainties regarding its clinical value and appropriate use. Uncertainty Tolerance (UT), a psychological construct that describes trait-level differences in individuals’ responses to uncertainty, may influence oncologists’ perceptions and attitudes regarding GTT.

Comments

Lambrew Research Retreat

Recommended Citation

Anderson, Eric; Hinton, Alexandra; Lary, Christine; Murray, Kimberly; Waterson, Leo; Han, Paul; and Maine Cancer Genomics Initiative, "The relationship between uncertainty tolerance and oncologists’ perceptions of large-panel genomic tumor testing" (2019). Maine Medical Center. 692.
https://knowledgeconnection.mainehealth.org/mmc/692